Researchers have developed a machine learning-based gene signature, NPC-RSS, to predict which nasopharyngeal cancer patients will benefit from radiotherapy.
Key Details
- 1A team at Southern Medical University created the NPC-RSS model using transcriptomic data from NPC patients.
- 2The model uses an 18-gene signature and was refined using 113 machine learning algorithm combinations.
- 3NPC-RSS demonstrated strong predictive accuracy in both internal and external validation datasets.
- 4Radiosensitive tumors showed richer immune cell activity, suggesting immune dynamics play a role in radiotherapy response.
- 5The tool aims to guide personalized radiotherapy decisions and reduce unnecessary treatment exposure.
- 6Further sample collection and international validation are ongoing to refine the model.
Why It Matters
Personalized radiotherapy guided by AI can improve outcomes in nasopharyngeal cancer by identifying patients most likely to benefit, addressing the challenge of radiation resistance. This tool could help clinicians tailor therapies, limit overtreatment, and improve patient survival.
Source
EurekAlert
Related News
•EurekAlert
Study Warns: AI Alone Is Not Enough in Critical Healthcare Decisions
Evaluating both AI algorithms and human users is key for safe adoption in high-stakes healthcare settings, according to an Ohio State study.
•EurekAlert
AI Dramatically Improves Prediction of Delivery Timing from Ultrasound Images
Ultrasound AI's study validates advanced AI for predicting delivery timing using standard ultrasound images.
•EurekAlert
AI-Assisted Colonoscopies May Reduce Clinicians’ Detection Skills, Study Finds
Routine use of AI in colonoscopies linked to decreased skill in adenoma detection by clinicians without AI assistance.